Loading…
Company announces positive results from clinical trial.
Vivos Therapeutics, Inc. announced Vivos Therapeutics' Vida® Appliance demonstrates enhancement in insomnia severity in 100% of patients in trial.
The announcement cited 100%.
Vivos Therapeutics, Inc. has a free float of 3,192,484 shares and 13,894,600 shares outstanding.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.